Wave Chasing Huntington’s Accelerated Approval Based On Caudate Atrophy Surrogate

 
• By Alaric DeArment
  
Wave believes a registrational trial with about 150 patients could last 12 to 18 months. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D